Bharat Biotech on Tuesday mentioned it has been supplying its vaccine, Covaxin, on to 18 states since Might 1 and can proceed to take action.
“COVAXIN has been immediately provided to 18 states since Might 1st. Unflinching in our efforts, we are going to proceed the regular provide of our #vaccine,” Bharat Biotech mentioned in a tweet.
The states embrace Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh and West Bengal, the Hyderabad-based agency added.
The corporate is supplying its vaccine to Andhra Pradesh, Assam, Bihar, Chhattisgarh, Delhi, Gujarat, Haryana, Jammu & Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Tripura, Telangana, Uttar Pradesh and West Bengal.
Bharat Biotech has commenced direct provide of Covaxin with impact from Might 1 to a number of states primarily based on the allocations acquired by the central authorities, the corporate’s joint managing director Suchitra Ella had earlier mentioned.
On April 29, Bharat Biotech had slashed the value of Covaxin for states to Rs 400 per dose from the sooner Rs 600.
This adopted widespread criticism of its pricing coverage because it bought Covaxin to the central authorities at Rs 150 per dose.
India has expanded its Covid-19 vaccination drive by permitting its massive 18-plus inhabitants to get inoculated from Might 1.
(With PTI inputs)
For in-depth, goal and extra importantly balanced journalism, Click on right here to subscribe to Outlook Journal